Form 8-K - Current report:
SEC Accession No. 0001193125-24-285929
Filing Date
2024-12-27
Accepted
2024-12-27 16:13:59
Documents
20
Period of Report
2024-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d875384d8k.htm   iXBRL 8-K 47581
2 EX-4.1 d875384dex41.htm EX-4.1 77979
3 EX-4.2 d875384dex42.htm EX-4.2 81429
4 EX-5.1 d875384dex51.htm EX-5.1 10418
5 EX-10.1 d875384dex101.htm EX-10.1 50064
6 EX-10.2 d875384dex102.htm EX-10.2 174455
7 EX-99.1 d875384dex991.htm EX-99.1 13587
8 EX-99.2 d875384dex992.htm EX-99.2 12610
  Complete submission text file 0001193125-24-285929.txt   722181

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA vinc-20241220.xsd EX-101.SCH 2839
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vinc-20241220_lab.xml EX-101.LAB 18738
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vinc-20241220_pre.xml EX-101.PRE 11700
22 EXTRACTED XBRL INSTANCE DOCUMENT d875384d8k_htm.xml XML 3767
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

EIN.: 833197402 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39244 | Film No.: 241585870
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)